Status: Recruiting
CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD
The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.
Participants needed: 200
Trial details
Age: 7-17Biological sex: AllType: InterventionalSponsor: Baylor College of MedicineUpdated: Jul 20, 2025Locations: 1
Eligibility criteria
The child is between the ages of 7 to 17 at enrollment with a primary diagnosis... [+3]
The child has a diagnosis of lifetime DSM-5 bipolar disorder, psychotic disorder... [+3]